ROS1 and non-small cell lung carcinoma: When the 191 ROS1+ NSCLC samples with known PD-L1 status were analyzed, the distribution by PD-L1 expression were: 0% (n = 34), 1–49% (53), and > 50% (104) (Supplementary Table 5).